Business ❯ Corporate Governance

Investor Relations

Securities Fraud Financial Reporting Securities Shareholder Rights Public Companies Shareholder Communication Shareholder Activism Shareholder Actions Stock Market Market Performance

Perrigo Investors Face Jan. 16, 2026 Deadline to Seek Lead Role in Securities Suit Over Formula Unit

Plaintiffs accuse Perrigo of concealing costly problems at its Nestlé-acquired formula unit, inflating reported performance.

Inspire Medical Investors Face Jan. 5 Deadline in Lawsuits Over Troubled Inspire V Rollout

Law Firms Press Telix Investors as Jan. 9 Lead-Plaintiff Deadline Nears in Securities Suits

Integer Holdings Investors Face Feb. 9 Lead‑Plaintiff Deadline in SDNY Securities Suit

Stride Securities Lawsuit: Investors Face Jan. 12 Deadline to Seek Lead-Plaintiff Role

Synopsys Securities Class Action Advances as Firms Urge Investors to Seek Lead Role Before Dec. 30

StubHub IPO Class Actions Expand as New Firm Seeks Lead Plaintiffs Before Jan. 23 Deadline

CarMax Securities Case: Investors Face Jan. 2 Deadline to Seek Lead Plaintiff Role

James Hardie Investors Face Lead‑Plaintiff Deadline Today in Securities Class Action

SLM Hit With Investor Class Action Over Private Loan Delinquency Claims

Skye Bioscience Investors Face Jan. 16 Lead-Plaintiff Deadline in Lawsuit Over Nimacimab Claims

Stories older than 24h

Coupang Breach Triggers Korea Task Force and U.S. Investor Suits

CarMax Securities Suit Spurs New Investor Solicitations as Jan. 2 Lead-Plaintiff Deadline Looms

Geely Takes Zeekr Private as Merger Closes and NYSE Listing Ends

Synopsys Investors Face Dec. 30 Lead-Plaintiff Deadline in Securities Class Action

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Securities Suit Over Inspire V Rollout

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action

F5 Faces Securities Class Action Over Alleged Concealment of Prolonged Breach

Multiple Securities Class Actions Target Coupang Over Alleged Undisclosed Cyber Breach

Jan. 16 Deadline Nears in Skye Bioscience Investor Class Actions